Gastroenterology

Females and older patients had higher rates of hospitalizations with CDI than males and younger patients.

Marla Dubinsky, MD, discusses what needs to be done to improve care for children with ulcerative colitis.

Researchers recently completed a 16-week phase 2b trial for patients with ulcerative colitis.

Marla Dubinsky, MD, discusses what adding adalimumab to the pediatric ulcerative colitis toolbox means for treatment strategies.

New data affirms a low rate of hepatitis B vaccination responsiveness among patients with hepatitis B core antibodies.

The study authors said that decentralizing dispensation of hepatitis C treatment re-engages patients.

There is a need for cost-effective treatments for HCV in low-income countries.

The amount of minimally invasive surgeries has increased between 2010-2017.

New data has investigators caution against the discontinuation of ulcerative colitis treatment, due to threat of relapse.

COVID-19 patients receiving at least 2 antibiotics were at a higher CDI risk.

Direct-acting antivirals have been a major milestone in the treatment of hepatitis C virus, new data show they also work in nearly all children, without serious adverse events.

ABX464 is being tested for numerous indications, including ulcerative colitis.

Raising awareness about proper treatment adherence is one method of working toward eliminating hepatitis C.

More than 90% of patients with hepatitis C who sought care at a comprehensive community health clinic completed treatment, and three-quarters of those returned for sustained virologic response testing.

Patients with C. diff infections had nearly a 5 day longer length of hospital stay than a group without CDI.

Dr. Nigel Bunnett talks about future plans to test a new IBD treatment.

Medtronic claims the GI Genius module will help clinicals identify lesions in real time during a colonoscopy.

Infliximab and ustekinumab have similar efficacy and speed of onset in patients with Crohn’s disease who are biologic-naïve.

“[sCD163] showed a significant decline in eradicated cases of HCC after treatment,” the study authors wrote.

There were no drug-related serious adverse events found in the study.

Researchers are preparing to study the treatment in IBD patients.

Changes have been made to managing acute severe ulcerative colitis during COVID-19, including intravenous steroids, rescue therapy, and surgical approaches.

Most patients who were treated with direct-acting antivirals for hepatitis C virus infection saw improvement in oral lichen planus symptoms, including 6 of 10 who saw complete remission.

Individuals with malnutrition had higher mortality rates, as well as higher rates of sepsis and pneumonia.

Investigators determined that acid-base disturbances like lactate clearance influenced C diff infection after cardiac surgery.